Effects of Pirfenidone on Survival and Functional/Radiological Evolution in Patients with Idiopathic Pulmonary Fibrosis (IPF): A Real-Life, Retrospective, Single Center, Observational Study

被引：0
|
作者：
De Magistris, S. [1 ]
Tavanti, L. [1 ]
Romei, C. [2 ]
Perrone, E. [2 ]
Lazzeretti, M. [1 ]
Celi, A. [1 ]
Falaschi, F. [1 ]
Palla, A. [1 ]
机构：
[1] Azienda Osped Univ Pisana, Dip Cardiotoracovasc, Pisa, Italy
[2] Azienda Osped Univ Pisana, Dip Radiodiagnost Radiol Vasc Intervent & Med Nuc, Pisa, Italy
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1657
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-life experience with pirfenidone in idiopathic pulmonary fibrosis (IPF) in a single centre in Italy. A retrospective study
    Tavanti, Laura
    De Magistris, Sara
    Romei, Chiara
    Perrone, Elisabetta
    Falaschi, Fabio
    Nieri, Dario
    Serradori, Massimiliano
    Celi, Alessandro
    Palla, Antonio
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [2] Real-life data on the safety and tolerability of Pirfenidone versus Nintedanib in Idiopathic Pulmonary Fibrosis (IPF) patients: A single-centre retrospective study
    Yin, Lorraine Thong Wan
    Bowen, Bernadette
    Henry, Micahel
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [3] Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis
    Vancheri, Carlo
    Sebastiani, Alfredo
    Tomassetti, Sara
    Pesci, Alberto
    Rogliani, Paola
    Tavanti, Laura
    Luppi, Fabrizio
    Harari, Sergio
    Rottoli, Paola
    Ghirardini, Alessandra
    Kirchgaessler, Klaus-Uwe
    Albera, Carlo
    [J]. RESPIRATORY MEDICINE, 2019, 156 : 78 - 84
  • [4] Real-life Data on the Safety and Tolerability of Pirfenidone versus Nintedanib in Idiopathic Pulmonary Fibrosis (IPF) Patients: A Single-Centre Study
    Thong, L.
    Bowen, B.
    Henry, M. T.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 1) : S28 - S29
  • [5] Study of overall survival associated with nintedanib and pirfenidone in patients with idiopathic pulmonary fibrosis: a real-life comparison
    Mazzoleni, Ludovica
    Borsino, Cecilia
    Zovi, Andrea
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2023, 30 (02) : E11 - E11
  • [6] Real-Life Experience with Pirfenidone in Idiopathic Pulmonary Fibrosis in Argentina. A Retrospective Multicenter Study
    Matias Caro, Fabian
    Laura Alberti, Maria
    Campins, Federico
    Ignacio Enghelmayer, Juan
    Eduardo Fernandez, Martin
    Lancellotti, Diana
    Papucci, Tulio
    Adrian Sebastiani, Javier
    Paulin, Francisco
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2019, 55 (02): : 75 - 80
  • [7] Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis
    Cameli, Paolo
    Bergantini, Laura
    D'Alessandro, Miriana
    Refini, Rosa Metella
    Pieroni, Maria
    Alonzi, Valerio
    Sestini, Piersante
    Bargagli, Elena
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [8] Efficacy and safety of pirfenidone in patients with IPF. A single center real-life experience
    Tzouvelekis, Argyris
    Karampitsakos, Theodoros
    Bouros, Evangelos
    Tzilas, Vasilios
    Antonou, Xrisoula
    Koulouris, Nikolaos
    Bouros, Demosthenes
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [9] The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting
    Santos, Gabriela
    Fabiano, Andre
    Mota, Patricia Caetano
    Rodrigues, Ines
    Carvalho, Diogo
    Melo, Natalia
    Novais-Bastos, Helder
    Alexandre, Andre Terras
    Moura, Conceicao Souto
    Guimaraes, Susana
    Pereira, Jose Miguel
    Carvalho, Andre
    Morais, Antonio
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 83
  • [10] Effectiveness of pirfenidone in idiopathic pulmonary fibrosis: results from a real-life study
    Rivano, M.
    Uda, M. E.
    Corda, G. M.
    Vacca, V.
    Aledda, L.
    Deidda, S.
    Zucca, C.
    Lombardo, F.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1551 - 1552
12345